Effects of repeated-dose isradipine on the abuse liability of cocaine. |
| |
Authors: | Roache, John D. Johnson, Bankole A. Ait-Daoud, Nassima Mauldin, James B. Thornton, Joe E. Wells, Lynda T. Murff, William L. |
| |
Abstract: | Despite preclinical studies suggesting that isradipine may antagonize the abuse liability of cocaine, pretreatment with sustained-release isradipine did not reduce euphoric mood in cocaine-using volunteers. This double-blind, within-subject, crossover laboratory study determined whether maximal dose-loading with isradipine could antagonize effects of cocaine in 12 cocaine-dependent research volunteers administered intravenous cocaine doses (0, 0.325, and 0.65 mg/kg) on different days after 5 days of treatment with isradipine or placebo. Isradipine dose was 30 mg sustained release nightly plus 15 mg immediate release 2 hr before cocaine infusion. Cocaine produced dose-related increases in cocaine's subjective effects and a behavioral measure of reinforcement. Isradipine enhanced, rather than antagonized, subjective effects, indicating that isradipine does not antagonize cocaine's abuse liability in dependent research volunteers. (PsycINFO Database Record (c) 2010 APA, all rights reserved) |
| |
Keywords: | cocaine isradipine drug abuse calcium channel antagonists treatment abuse liability cocaine antagonists drug interaction cocaine potentiation |
|
|